UNSPSC 51111878: Goserelin acetate

Goserelin is a medication which is used to suppress production of the sex hormones, particularly in the treatment of breast and prostate cancer.

UNSPSC 51111878 Goserelin acetate, a Commodity code, encompasses pharmaceutical products that state and local governments procure for health and clinical operations, though the recent opportunities block shows minimal activity directly aligned with this specific drug product. Instead, the documented solicitations reflect broader pharmaceutical procurement across emergency medical services, forensic laboratory operations, pharmacy benefits programs, and multi-state cooperative purchasing for generic and OTC products. The issuing bodies span county health departments, fire departments, forensic laboratories, and state purchasing alliances; Seminole County, Florida and the City of Tucson, Arizona appear in recent competitive solicitations for medical supplies and pharmaceuticals, while Minnesota's multistate cooperative (MMCAP) administers a statewide procurement for generic pharmaceutical contracting. Most documented activity involves health system procurement rather than specialty pharmaceutical products like goserelin acetate, suggesting the code captures a narrow niche within larger pharmaceutical spending.

Geographically, recent pharmaceutical solicitations concentrate in Florida (Seminole County naloxone and drug deactivation systems, Pinellas County forensic drug standards), Arizona (Tucson Fire Department BLS/ALS pharmaceuticals and supplies through an RFP with response due June 24, 2026), Minnesota (MMCAP generic and OTC products RFP due March 26, 2026), and Arkansas (Little Rock Fire Department medical oxygen cylinder rental ITQ due February 6, 2026). The Minnesota MMCAP opportunity is the largest documented, establishing multiple contracts for generic pharmaceuticals across participating state and local facilities with authorized wholesaler distribution through AmerisourceBergen (Cencora), Cardinal Health, and Morris & Dickson. However, none of these recent opportunities explicitly solicit goserelin acetate or comparable specialty oncology pharmaceuticals; the code's recent state and local activity appears dormant or misaligned with the commodities actually being procured under it.